A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma	Active, not recruiting	Phase 2	2026-05-19		NCT06378177

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Lyvgen Biopharma Holdings Limited	2

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Cancer Hospital	Hefei	China	2
Beijing Cancer Hospital	Beijing	China	208
Beijing Tongren Hospital affiliated to Capital Medical University	Beijing	China	5
Fujian Cancer Hospital	Fuzhou	China	109
Guangxi Medical University Cancer Hospital	Nanning	China	24
Henan Cancer Hospital	Zhengzhou	China	67
Hunan Cancer Hospital	Changsha	China	27
Liaoning Cancer Hospital	Shenyang	China	15
Shanghai Oriental Hospital	Shanghai	China	2
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou	China	67
The Second Xiangya Hospital, Central South University	Changsha	China	4
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	71
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	37
West China Hospital of Sichuan University	Chengdu	China	117
Xiangya Hospital Central South University	Changsha	China	35
Zhejiang Cancer Hospital	Hangzhou	China	164